World Health Organization bacterial priority pathogens in skin and soft tissue infections: prevalence, antimicrobial resistance, and risk factors in Mwanza, Tanzania.

Vitus Silago, Katarina Oravcova, Louise Matthews, Stephen E Mshana, Heike Claus, Jeremiah Seni

Abstract read

In one paragraph

Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vitus SilagoCatholic University of Health and Allied Sciences, Weill Bugando School of Medicine, Department of Microbiology and Immunology, Mwanza, Tanzania.

Katarina OravcovaUniversity of Glasgow, School of Biodiversity, One Health & Veterinary Medicine, Glasgow, UK.

Louise MatthewsUniversity of Glasgow, School of Biodiversity, One Health & Veterinary Medicine, Glasgow, UK.

Stephen E MshanaCatholic University of Health and Allied Sciences, Weill Bugando School of Medicine, Department of Microbiology and Immunology, Mwanza, Tanzania.

Heike ClausUniversity of Würzburg, Institute for Hygiene and Microbiology, Würzburg, Germany.

Jeremiah SeniCatholic University of Health and Allied Sciences, Weill Bugando School of Medicine, Department of Microbiology and Immunology, Mwanza, Tanzania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Antimicrobial resistance, particularly among World Health Organization bacterial priority pathogens (WHO BPPs), poses a major global health threat. We assessed the epidemiology of wound infections, including bacterial profiles, WHO BPP burden, and associated factors, during and after the implementation of the National Action Plan on Antimicrobial Resistance (NAP-AMR) in Mwanza, Tanzania. Methods: A cross-sectional study was conducted during (June 2019 to June 2020) and after (March to August 2023) NAP-AMR. Pus samples were cultured aerobically. Isolates were identified using Vitek mass spectrometry and 16S ribosomal ribonucleic acid sequencing. Antimicrobial susceptibility testing and minimum inhibitory concentrations were determined using Vitek 2. Results: Among 630 patients (median age 29 years; interquartile range 15-47), 257 (40.8%) had positive cultures. Skin and soft tissue infections increased significantly after NAP-AMR (27.8% vs 68.3%, Conclusion: After NAP-AMR, we recorded significant increases in resistance to 3GCs among

Indexed as

Action plan on antimicrobial resistanceGram-negative bacteriaGram-positive bacteriaSkin and soft tissue infectionsWHO bacterial priority pathogens

Identifiers

PMID42382011

DOI10.1016/j.ijregi.2026.100926

PMCPMC13315106

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.